Immune to Cancer: The CRI Blog
-
Esophageal Cancer Awareness Month: 2020 Immunotherapy Research Update
Promising new research, a variety of immunotherapy treatment combinations, and how we’re working toward a future immune…
-
How Immunotherapy for Esophageal Cancer is Making an Impact
Dr. Deirdre Cohen discusses recent advances in immunotherapy for esophageal cancer, including biomarkers, checkpoint inhibitors, cell-based therapies,…
-
Head and Neck Cancer Awareness Month: 2020 Immunotherapy Research Update
HPV’s connection to head and neck cancer, treatment options, side effects, and how we’re working toward a…
-
Defining Resistance to Treatment with Anti-PD-1/PD-L1 Immunotherapy
CRI's Vanessa M. Lucey, Ph.D, MBA, helps guide the design and analysis of future clinical trials involving…
-
CRI Scientists Fighting the Novel Coronavirus Pandemic
CRI’s focus on immunology research—while primarily aimed at curing cancer—also has contributed to advances in the treatment…
-
Meet the Five Inaugural Lloyd J. Old STARs
We spoke with the five inaugural CRI Lloyd J. Old STARs to learn more about their work…
-
Vaccine-Chemo Combo Shows Promise in Treating Advanced, HPV-Associated Cervical Cancer
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with…
-
COVID-19 and the Immune System: How Cancer Research Can Help Rein in the Novel Coronavirus Pandemic
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.
-
COVID-19 y el sistema inmunitario: cómo la investigación del cáncer puede ayudar a frenar la pandemia del nuevo coronavirus
Las lecciones aprendidas de la investigación sobre inmunoterapia contra el cáncer pueden ayudar a frenar la pandemia…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.